Anuh Pharma Ltd.
BSE: 506260 | Sector: Health care |
NSE: N.A. | ISIN Code: INE489G01022 |
BSE 11:04 | 28 Jan | 128.05 |
1.65 (1.31%) |
OPEN
125.25 |
HIGH
128.10 |
LOW
124.30 |
NSE 05:30 | 01 Jan | Anuh Pharma Ltd |
OPEN | 125.25 |
PREVIOUS CLOSE | 126.40 |
VOLUME | 14493 |
52-Week high | 218.70 |
52-Week low | 48.70 |
P/E | 22.31 |
Mkt Cap.(Rs cr) | 642 |
Buy Price | 128.00 |
Buy Qty | 882.00 |
Sell Price | 128.05 |
Sell Qty | 51.00 |
Anuh Pharma Ltd. (ANUHPHARMA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 951.50 | -7.95 | -0.83 | 13266.48 |
Cipla | 847.25 | 5.15 | 0.61 | 12659.15 |
Sun Pharma.Inds. | 569.25 | -0.55 | -0.10 | 12531.93 |
Dr Reddy's Labs | 4890.00 | -18.85 | -0.38 | 11850.40 |
Lupin | 1075.95 | 1.70 | 0.16 | 11025.66 |
Apollo Hospitals | 2609.50 | 10.05 | 0.39 | 9794.50 |
Glenmark Pharma. | 488.00 | 2.50 | 0.51 | 6712.63 |
Alkem Lab | 3030.00 | -29.55 | -0.97 | 6677.08 |
Cadila Health. | 465.55 | 3.35 | 0.72 | 6347.40 |
Torrent Pharma. | 2620.25 | -26.00 | -0.98 | 6168.44 |
Divi's Lab. | 3455.00 | -28.90 | -0.83 | 5310.57 |
Ipca Labs. | 1914.00 | -30.30 | -1.56 | 4337.82 |
Piramal Enterp. | 1402.75 | -18.45 | -1.30 | 4219.19 |
Alembic Pharma | 943.65 | -8.60 | -0.90 | 4132.55 |
Abbott India | 14490.90 | -40.45 | -0.28 | 4093.14 |
Glaxosmi. Pharma | 1463.00 | -6.05 | -0.41 | 3224.68 |
Jubilant Life | 915.00 | -12.20 | -1.32 | 3139.90 |
Sanofi India | 8025.25 | 34.80 | 0.44 | 3070.60 |
Laurus Labs | 362.05 | -4.15 | -1.13 | 2797.34 |
Gland Pharma | 2175.25 | -9.40 | -0.43 | 2633.24 |
Quick Links for Anuh Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices